Published in Z Kardiol on May 01, 1974
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation (1997) 4.09
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol (1998) 3.03
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet (1994) 2.39
xIAP induces cell-cycle arrest and activates nuclear factor-kappaB : new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ Res (2001) 2.10
Clinical evaluation of no-carrier-added meta-[123I]iodobenzylguanidine for myocardial scintigraphy. Eur J Nucl Med (2000) 2.06
Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation (1990) 2.05
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. Eur Heart J (1999) 1.98
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J (2000) 1.92
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation (2001) 1.88
The natural history of aortic valve stenosis. Eur Heart J (1988) 1.72
Targeting the slow pathway for atrioventricular nodal reentrant tachycardia: initial results and long-term follow-up in 379 consecutive patients. Eur Heart J (2001) 1.71
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res (2000) 1.70
Molecular diagnosis in a child with sudden infant death syndrome. Lancet (2001) 1.66
Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol (1991) 1.63
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. Eur Heart J (1997) 1.61
Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation (1992) 1.61
An anatomically and electrogram-guided stepwise approach for effective and safe catheter ablation of the fast pathway for elimination of atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1995) 1.61
[Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies]. Z Kardiol (1996) 1.59
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial. Clin Res Cardiol (2006) 1.59
A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype. J Mol Med (Berl) (2001) 1.56
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation (1998) 1.54
Erroneous discharge of an implantable cardioverter defibrillator caused by an electric razor. Pacing Clin Electrophysiol (1995) 1.54
Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol (2004) 1.53
Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J (2000) 1.52
Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic "anchor" reentrant circuits. J Cardiovasc Electrophysiol (1999) 1.52
Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies. Eur Heart J (2000) 1.51
Extracardiac contributions to chest pain perception in patients 6 months after acute myocardial infarction. Am Heart J (1999) 1.50
Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol (1999) 1.49
Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation. Eur Heart J (1995) 1.47
Task Force Report: The legal implications of medical guidelines--a Task Force of the European Society of Cardiology. Eur Heart J (1999) 1.47
Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy. Heart (2007) 1.45
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Doppler echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy. Am J Cardiol (1992) 1.43
[18-year old patient with anti-epileptic therapy and sudden cardiac death]. Z Kardiol (2003) 1.41
The Percutaneous Cardiac Mapping and Ablation Registry: final summary of results. Pacing Clin Electrophysiol (1988) 1.39
Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J (1991) 1.39
Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation (1997) 1.39
Percutaneous coronary interventions using a new 5 French guiding catheter: results of a prospective study. Catheter Cardiovasc Interv (2001) 1.39
[The recanalization of the chronically occluded infarct vessel in single-vessel coronary disease. The reduction of cardiac events in long-term clinical follow-up]. Dtsch Med Wochenschr (1995) 1.39
[The therapy of coronary heart disease. The current aspects]. Dtsch Med Wochenschr (1991) 1.39
Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems? J Cardiovasc Electrophysiol (1999) 1.39
Temperature-controlled radiofrequency catheter ablation of manifest accessory pathways. Eur Heart J (1996) 1.39
Implantable cardioverter/defibrillators (ICD): a new lead-system using transvenous-subcutaneous approach in patients with prior cardiac surgery. Eur J Cardiothorac Surg (1991) 1.38
Contribution of heart rate variability to long-term risk stratification after myocardial infarction. Eur Heart J (1997) 1.38
Effects of enflurane on inducibility of ventricular tachycardia. Am J Cardiol (1991) 1.38
Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation (1994) 1.38
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol (1999) 1.34
Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM). Postgrad Med J (1978) 1.28
Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation (1999) 1.18
Isolated noncompaction of the left ventricular myocardium -- a review of the literature two decades after the initial case description. Clin Res Cardiol (2007) 1.18
The LQT syndromes--current status of molecular mechanisms. Z Kardiol (1999) 1.18
Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation (1994) 1.17
Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. Circulation (1998) 1.16
Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J (1983) 1.15
Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response. Heart (2004) 1.13
Single-incision implantation of cardioverter defibrillators using nonthoracotomy lead systems. Ann Thorac Surg (1994) 1.12
Experimental models of torsade de pointes. Cardiovasc Res (1998) 1.11
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J (1999) 1.10
Recording of left atrial potentials from pulmonary artery in man. Br Heart J (1980) 1.09
Potential benefit from implantable cardioverter-defibrillator therapy in children and young adolescents. Heart (2004) 1.09
Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size. Pacing Clin Electrophysiol (1996) 1.08
In vivo evaluation of the Lillehei-Kaster heart valve prosthesis. Ann Thorac Surg (1976) 1.07
Pacemaker-induced ventricular tachycardia in normally functioning ventricular demand pacemakers. Am J Cardiol (1989) 1.06
Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3. Basic Res Cardiol (2005) 1.05
Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace (2002) 1.05
Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol (2002) 1.05
Fetoscopic transesophageal electrocardiography and stimulation in fetal sheep: a minimally invasive approach aimed at diagnosis and termination of therapy-refractory supraventricular tachycardias in human fetuses. Circulation (1999) 1.04
Effects of verapamil on sinus node function in man. Eur J Cardiol (1978) 1.04
Radiofrequency coagulation of ventricular myocardium: improved prediction of lesion size by monitoring catheter tip temperature. Eur Heart J (1989) 1.04
Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol (2001) 1.02
QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart (2003) 1.02
Variants of preexcitation--specialized atriofascicular pathways, nodofascicular pathways, and fasciculoventricular pathways: electrophysiologic findings and target sites for radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1996) 1.01
Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg (1999) 1.01
Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.00
[Diagnostic and prognostic value of endomyocardial biopsy in patients with congestive cardiomyopathy (author's transl)]rdiomyopathy(author. Dtsch Med Wochenschr (1975) 1.00
Emergency coronary artery bypass grafting after failed coronary angioplasty: what has changed in a decade? Ann Thorac Surg (2000) 1.00
Localization and radiofrequency catheter ablation of left-sided accessory pathways during atrial fibrillation. Feasibility and electrogram criteria for identification of appropriate target sites. J Am Coll Cardiol (1995) 1.00
Influence of sampling site and flow area on cardiac output measurements by Doppler echocardiography. J Am Coll Cardiol (1987) 0.99
Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol (2000) 0.99
Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.98
Sinus node recovery time and calculated sinoatrial conduction time in normal subjects and patients with sinus node dysfunction. Circulation (1977) 0.98